UNSPSC 51101656: Emodepside

This classification denotes an antihelminthic agent with the molecular formula C60H90N6O14, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier YZ647Y5GC9. The term EMODEPSIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 15 no. 3-4, 2001, list 46. ). Most nations schedule emodepside under HS 29349990 and SITC 51579. As of Q4 2014, EMODEPSIDE remains the US FDA Preferred Term for this commodity. Emodepside bears US NLM identifiers UMLS ID C1172566 and NCI Concept Code C90726.

SMILES: CC1C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)OC(C(=O)N(C(C(=O)O1)CC(C)C)C)CC2=CC=C(C=C2)N3CCOCC3)CC(C)C)C)C)CC(C)C)C)CC4=CC=C(C=C4)N5CCOCC5)CC(C)C)C.

UNSPSC 51101656 Emodepside is a Commodity code representing pharmaceutical products and related supplies procured by state and local health agencies. Recent state and local opportunities under this code show government acquisition of naloxone, drug deactivation systems, and other pharmaceutical warehouse supplies through cooperative purchasing vehicles and competitive bidding. The issuing bodies include state departments of public health and county health systems, typically soliciting through piggyback contracts, IFB notices, and cooperative consortiums to support community health and emergency response initiatives. Work under the code encompasses the supply of finished pharmaceuticals in bulk quantities with specified packaging, expiration profiles, and delivery schedules to support public health warehouse operations and community distribution networks.

Seminole County, Florida and the Illinois Department of Public Health represent recent activity in the code's geographic scope. The Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract to Chartwell Rx LLC on August 28, 2026, for $2,999,999.11 over 12 months plus two renewal years through the MMCAP Infuse cooperative purchasing consortium, supplying doxycycline hyclate and ciprofloxacin hydrochloride tablets to state health stockpiles. Seminole County, Florida issued an IFB on June 30, 2026, with a July 26, 2023, response deadline for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford; the contract included a two-year initial term plus one-year renewal option and was potentially funded through FEMA, introducing federal compliance requirements including the Clean Air Act and Federal Water Pollution Control Act.